Surface Oncology Current Ratio 2011-2026 | SURF

Annual Current Ratio Surface Oncology

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.4	2.65	3.54	5.6	6.06	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.06	2.4	4.05

Quarterly Current Ratio Surface Oncology

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.92	2.24	2.4	2.64	-	3.08	2.65	3.29	3.58	3.86	3.54	3.54	3.54	3.54	1.76	1.76	1.76	1.76	2.44	2.44	2.44	2.44	0.81	0.81	0.81	0.81	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.92	0.81	2.47

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	7.02	$ 5.15	15.21 %	$ 12.4 B	Australia
Allakos ALLK	3.26	-	-	$ 28.6 M	USA
AlloVir ALVR	2.84	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Applied Molecular Transport AMTI	2.31	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Applied Therapeutics APLT	0.762	-	-	$ 8.42 M	USA
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Midatech Pharma plc MTP	2.68	-	-18.52 %	$ 27.3 M	Britain
Aligos Therapeutics ALGS	2.53	$ 6.51	-2.54 %	$ 64.4 M	USA
Amphastar Pharmaceuticals AMPH	1.94	$ 22.92	0.17 %	$ 1.07 B	USA
Avenue Therapeutics ATXI	2.67	-	-52.27 %	$ 4.45 M	USA
BioNTech SE BNTX	7.95	$ 105.19	2.21 %	$ 27.2 B	Germany
Aravive ARAV	1.21	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Can-Fite BioPharma Ltd. CANF	2.76	$ 3.0	-1.32 %	$ 4.94 M	Israel
Aeterna Zentaris AEZS	1.22	-	5.93 %	$ 314 M	Canada
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	0.0929	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	1.09	$ 1.43	1.78 %	$ 368 M	USA
BioDelivery Sciences International BDSI	2.37	-	-4.8 %	$ 255 M	USA
Ayala Pharmaceuticals AYLA	6.43	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
Aquestive Therapeutics AQST	0.827	$ 4.24	-1.85 %	$ 453 M	USA
Arcutis Biotherapeutics ARQT	1.78	$ 24.47	-0.24 %	$ 3.11 B	USA
Burford Capital Limited BUR	2.14	$ 4.99	0.6 %	$ 804 M	Britain
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Autolus Therapeutics plc AUTL	1.43	$ 1.58	-1.25 %	$ 420 M	Britain
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
BioXcel Therapeutics BTAI	0.32	$ 1.2	4.35 %	$ 14.6 M	USA
AVROBIO AVRO	15.9	-	1083.1 %	$ 745 M	USA
Cabaletta Bio CABA	3.11	$ 3.31	-3.92 %	$ 333 M	USA
bluebird bio BLUE	1.46	-	-	$ 546 M	USA
Fennec Pharmaceuticals FENC	2.01	$ 6.73	-0.88 %	$ 192 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
CymaBay Therapeutics CBAY	3.05	-	-	$ 3.45 B	USA
Cidara Therapeutics CDTX	4.17	-	-	$ 1.41 B	USA
ChromaDex Corporation CDXC	3.56	-	-0.88 %	$ 598 M	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA
ContraFect Corporation CFRX	0.636	-	-5.16 %	$ 5.39 M	USA